Analytical Data
-
Gene name
MYH14
- Application
-
Alternative Names
MYH14；KIAA2034；Myosin-14
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7Z406
-
Expression Region
全长
-
AA Sequence
full
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYH14, a member of the myosin superfamily, encodes a class II myosin heavy chain that plays a crucial role in various cellular processes, including muscle contraction, cell motility, and intracellular transport. Research has shown that MYH14 is involved in the development and function of different tissues, particularly in the heart and skeletal muscle. Its dysregulation has been linked to several pathological conditions, including cardiac hypertrophy and other muscular disorders. The recombinant MYH14 protein serves as an essential tool for studying its biochemical properties, interaction with actin filaments, and functional roles within cells. By producing MYH14 in a recombinant system, researchers can obtain large quantities of the protein for in vitro assays, functional studies, and structural analyses. This approach facilitates the exploration of MYH14's mechanisms of action, its regulatory pathways, and its potential implications in disease states. Recent advancements in protein expression techniques have further enhanced the understanding of MYH14's function in cellular architecture and pathophysiology, providing insights that could lead to novel therapeutic targets for myopathies and cardiovascular diseases. Overall, the study of recombinant MYH14 protein is vital for elucidating the complexities of muscle and cardiac biology, as well as for developing strategies to mitigate related disorders.
